Watch for Elevated BPs From Injectable CGRP Antagonists
You may see patients presenting to your ED with elevated BPs from taking an injectable CGRP antagonist used for migraine prophylaxis.
Most data suggest that erenumab (Aimovig) or other CGRP antagonists have minimal CV impact. But it's mostly short-term data in young patients without CV risks.
Now an FDA review suggests new-onset or worsening hypertension with erenumab...prompting labeling updates.